Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

Abstract Background Colorectal cancer (CRC) remains a serious health concern worldwide. Despite advances in diagnosis and treatment, about 15 to 30% of stage II CRC patients subjected to tumor resection with curative intent, develop disease relapse. Moreover, the therapeutic strategy adopted after s...

Full description

Bibliographic Details
Main Authors: Sara Ribeirinho-Soares, Diana Pádua, Ana Luísa Amaral, Elvia Valentini, Daniela Azevedo, Cristiana Marques, Rita Barros, Filipa Macedo, Patrícia Mesquita, Raquel Almeida
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Cancer
Subjects:
Stage II colorectal cancer
Biomarkers
MUC2
CDX2
SOX2
Online Access:https://doi.org/10.1186/s12885-021-08070-6

Internet

https://doi.org/10.1186/s12885-021-08070-6

Similar Items